J Neurol Surg Rep 2014; 75(01): e122-e128
DOI: 10.1055/s-0034-1376425
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Cavernous Sinus Angioleiomyoma: Case Report and Review of the Literature

Yu Teranishi
1   Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, Japan
,
Michihiro Kohno
1   Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, Japan
,
Shigeo Sora
1   Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, Japan
,
Hiroaki Sato
1   Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, Japan
,
Munehiro Yokoyama
2   Department of Pathology, Tokyo Metropolitan Police Hospital, Tokyo, Japan
› Institutsangaben
Weitere Informationen

Address for correspondence

Yu Teranishi, MD
Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital
4-22-1, Nakano, Nakano-ku, Tokyo
Japan   

Publikationsverlauf

05. Oktober 2013

15. März 2014

Publikationsdatum:
04. Juni 2014 (online)

 

Abstract

Cavernous sinus angioleiomyoma (ALM) is extremely rare. Only three cases have been reported to be cavernous sinus ALM, and very few reports described characteristic findings for intracranial ALMs in detail. We report a new case of cavernous sinus ALM, with detailed information on the clinical presentation, radiology, pathology, and surgical approach. A 52-year-old woman had a 6-month history of right eye discomfort. Magnetic resonance imaging showed a right cavernous sinus tumor with heterogenous blush enhancement. Enhanced computed tomography scans and angiography showed small nodular enhancement in the tumor. Complete tumor resection was achieved via an extradural temporopolar approach. ALM was identified based on histologic examination. Intracranial ALMs are different from the ALMs that occur in the extremities based on our review of the literature. Intracranial ALMs appear more frequently in men than women. The cavernous type was the most common pathologically, and they occur often in the epiperidural location. Because cavernous sinus ALM occurs in the interdural space, an epidural approach should be selected. Therefore, it is important to include cavernous sinus ALM into a differential diagnosis of a cavernous sinus tumor. The blush enhancement and nodular enhancement within this lesion may be useful to distinguish cavernous sinus ALM from other differential diagnoses.


#

Introduction

Angioleiomyoma (ALM) is a soft tissue tumor that occurs most often in the skin and subcutaneous tissue in the lower extremities. Cavernous sinus ALM is extremely rare; so far only three cases have been reported as cavernous sinus ALM.[1] [2] [3] We present a new case of cavernous sinus ALM with an emphasis on clinical data, differential diagnosis, pathologic findings, and surgical approach. We also report new information, to the best of our knowledge, on radiologic findings.


#

Case Report

History and Examination

A 52-year-old woman visited a nearby hospital for a 6-month history of right eye discomfort. She was referred to our hospital for further examination and treatment. Her symptom was occurred gradually, without visual field defect and diplopia. The physical examination revealed no paralysis of cranial nerves III, IV, and VI. There was also no facial paresthesia. Ophthalmology examination revealed normal visual acuity in both eyes, and no visual field defect was found by visual field test.

Contrast-enhanced magnetic resonance imaging (MRI) of the brain showed an enhancing tumor arising from the right cavernous sinus. The diameter of the tumor was 23 mm. It was isointense on axial T1-weighted MRI scan, hyperintense on axial T2-weighted scan, and heterogeneously enhanced on contrast-enhanced MRI ([Fig. 1A–C]). The tumor eroded the superior orbital fissure, optic canal, and it deviated the optic nerve medially. This tumor was hypointense on axial diffusion-weighted images and coronal hyperintense on constructive interference in a steady state (CISS) image ([Fig. 1D, E]). CISS imaging indicated that the tumor was located between the layers of the lateral wall of the cavernous sinus. There was no tumor extension into Meckel cave. A bone computed tomography indicated no erosion of the foramen ovale or the foramen rotundum. There was no calcification in the tumor. According to these findings, the lesion was suspected to be a trigeminal schwannoma arising from V1, or an occulomotor nerve schwannoma.

Zoom Image
Fig. 1 Preoperative magnetic resonance imaging findings. (A) Axial T1: The lesion showed isointensity. (B) Contrast-enhanced axial T1: The lesion showed heterogenous enhancement. (C) Axial T2: The lesion showed hyperintensity. (D) Axial diffusion-weighted image: The lesion showed hypointensity. (E) Coronal constructive interference in a steady state: The lesion revealed that the tumor was located between the layers of the lateral wall of the cavernous sinus. Note the tumor (circle).

#

Operation

The patient underwent tumor resection via an extradural temporopolar approach with lumbar drainage. After frontotemporal craniotomy and elevation of the dura propria, we found the tumor was located between the layers of the lateral wall of the cavernous sinus. The tumor was elastic, dark red, vascularized, and bled easily. We debulked the tumor continuously using bipolar coagulation. After the tumor was resected completely, hemostatic agents were applied.


#

Pathologic Findings

The tumor tissue was stained with hematoxylin and eosin (H & E) and other immunohistochemical stains. The tumor was composed of dilated vascular channels with spindle cells ([Fig. 2A–C]). In terms of immunohistochemical studies, only endothelial cells were positive for CD34, whereas spindle cells were negative for CD34 ([Fig. 2D]). These spindle cells were positive for αSMA, h-Caldesmon, and calponin but were negative for EMA and S100 ([Fig. 2E–G]). Based on these pathologic findings, the tumor was diagnosed as a cavernous type of ALM.

Zoom Image
Fig. 2 Pathologic findings. (A–C) Dilated vascular channels intermingled with smooth muscle bundles (hematoxylin and eosin, ×100, ×400). (D) Endothelial cells showing strong positivity for CD34 (immunohistochemistry, ×400). (E–G) Smooth muscle bundles showing strong positivity for Calponin, h-Caldesmon, and αSMA (immunohistochemistry, ×400). (H) Ki-67 index was 2.1%.

#

Postoperative Course

After the operation, the patient presented with right abducens nerve palsy and diplopia. Except for these symptoms, the postoperative course was good. These symptoms improved completely in 2 weeks. Postoperative computed tomography (CT) and MRI indicated a complete tumor resection had been achieved ([Fig. 3]).

Zoom Image
Fig. 3 Postoperative neuroradiologic findings. (A) T1-weighted magnetic resonance (MR) images. (B) Contrast-enhanced T1-weighted MR images. (C) Computed tomography scans.

#
#

Discussion

ALMs are soft tissue tumors that occur commonly in the skin and subcutaneous tissue in the lower extremities. According to Hachisuga et al,[4] the tumor appears in middle-age individuals, mostly women. Cavernous sinus ALM is extremely rare; so far only three cases have been reported as cavernous sinus ALM.[1] [2] [3] Very few reports have described characteristic findings for intracranial ALMs in detail. [Tables 1], [2], and [3] summarize the clinical, radiologic, surgical, and pathologic findings in all previous reports about intracranial ALMs including our case.[1] [2] [3] [5] [6] [7] [8] [9] [10] [11] [12] [13] The data reviewed here show that intracranial ALMs were more frequently found in men (9 cases: men, 3 cases: women; 1 case: unknown) than in women in contrast to extremity ALMs (Table 1). The average age was 43.5 years (standard deviation [SD]:16). In terms of dural attachment, 11 cases were found in the extradural location or in the peridural location, and 3 cases appeared in the subdural location (Table 1). In all cases, surgical intervention was performed (12 cases: gross total resection; 1 case: subtotal resection; 1 case: biopsy). The symptom and its duration varied, as well as its size and location. Preoperative diagnosis for cavernous sinus ALM is considered difficult, and it is especially important to distinguish cavernous sinus ALM from cavernous sinus meningioma, trigeminal schwannoma, cavernous hemangioma, or hemangioblastoma.

Table 1

Clinical findings of previous reports

Age, y

Sex

Location

Size, mm

Symptoms

Duration of symptoms, mo

Approach

Removal

Lach et al8

47

M

Parietal lobe

20

Gait abnormality, parkinsonism

14

NA

GTR

Ravikumar et al9

12

F

Caudate nucleus

NA

Diplopia, headache, seizure

1.5

Frontal craniotomy

GTR

Kohan et al7

NA

NA

IAM

NA

Hearing loss, tinnitus

NA

Retrosigmoid

GTR

Figueiredo et al2

52

M

Cavernous sinus

60

Diplopia, headache, facial numbness, impaired visual acuity

6

Frontotemporal

GTR

Karagama et al6

47

F

IAM

1

Sensorineural hearing loss

12

Translabyrinthine

GTR

Colnat-Coulbois et al1

50

M

Cavernous sinus

NA

Headache, diplopia

NA

Frontotemporal, intradural

GTR

Vijayasaradhi et al12

10

F

Frontal intradiploic space

40

Headache

4

NA

GTR

Gasco et al5

43

M

Cerebellar lesion

44

Blurry vision, ataxia, headache

12

Suboccipital

GTR

Xu et al13

53

M

Sella

NA

Headache, visual deterioration

3

NA

GTR

Conner et al[11]

42

M

Tentorial incisura

10

Headache

3

Midline suboccipital

GTR

Conner et al[11]

36

M

Falx cerebri

25

Headache, lightheadedness

24

Interhemispheric

STR

Zhou et al3

62

M

Cavernous sinus

37

seizure

0

NA

GTR

Shinde et al10

60

M

Putamen, hippocampus

20

Headache, seizure

2

None

Biopsy

Present case

52

F

Cavernous sinus

23

Eye discomfort

6

Extradural temporopolar

GTR

Abbreviations: GTR, gross total resection; IAM, internal acoustic meatus; NA, not available; STR, subtotal resection.


Table 2

Radiologic findings of previous reports

Radiologic findings

Lach et al8

CT: Homogenous enhancement, no mass effect, large draining vein

Ravikumar et al9

CT: Enhanced mural nodule

Kohan et al7

NA

Figueiredo et al2

CT: Homogeneous enhancement, bone erosion; MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement; IC/optic chiasm displacement

Karagama et al6

MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement

Colnat-Coulbois et al1

MRI: T1, isointense; T2, hyperintense; Gd, heterogeneous enhancement

Vijayasaradhi et al12

NA

Gasco et al5

CT: Hyperdense; MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement

Xu et al13

MRI: T1, hypotense; T2, hyperintense

Conner et al[11]

MRI: T2, hyperintense; Gd, punctate enhancement

Conner et al[11]

CT: Homogeneous enhancement

Zhou et al3

MRI: T1, isointense; T2, hyperintense; Gd, heterogeneous enhancement; DWI, hypointense

Shinde et al10

MRI: T1, iso-hypointense; T2, hyperintense; Gd, homogeneous enhancement

Present case

MRI: T1, iso-hypointense; T2, hyperintense; Gd, heterogeneous enhancement; DWI, hypointense; CISS, hyperintense; enhanced CT: nodular tumor stains; angiography: nodular tumor stains

Abbreviations: CISS, constructive interference in steady state; CT, computed tomography; DWI, diffusion-weighted image; Gd, gadolinium; IC, internal capsule; MRI, magnetic resonance image; NA, not available.


Table 3

Pathologic findings of previous reports

Pathologic findings

Type of ALM

Lach et al8

Vessel walls: desmin (+), vimentin (+), SMA (+), myosin (+)

Mixed

Ravikumar et al9

Vessel walls: desmin (+), S100 (−), GFAP (−)

Solid

Kohan et al7

NA

NA

Figueiredo et al2

Vessel walls: vimentin (+), SMA (+), EMA (−), S100 (−), GFAP (−), MSA (−)

Cavernous

Karagama et al6

Vessel walls: SMA(+)

Cavernous

Colnat-Coulbois et al1

Vessel walls: vimentin (+), SMA (+), EMA (−), endothelial cells: CD31 (+), CD34 (+)

Cavernous

Vijayasaradhi et al12

Vessel walls: SMA (+), EMA (−), vimentin (−), S100 (−)

Solid

Gasco et al5

Vessel walls: SMA (+), endothelial cells only: CD34 (+), EMA (−), Ki-67 < 1%

Venous

Xu et al13

Vessel walls: desmin (+), vimentin (+), SMA (+), MSA (+), AE1/AE3 (−), S100 (−), GFAP (−), EMA (+), endothelial cells: CD31 (+), CD34 (+)

Cavernous

Conner et al[11]

Vessel walls: vimentin (+), SMA (+), MSA (+), endothelial cells: CD31 (+), CD34 (+), EMA (−), S100 (−)

Cavernous

Conner et al[11]

Vessel walls: vimentin (+), SMA (+), MSA (+), endothelial cells: CD31 (+), CD34 (+), EMA (−), S100 (−)

Cavernous

Zhou et al3

SMA (+), desmin (+), EMA (−), Ki-67 < 1%

Venous

Shinde et al10

Vimentin (+), SMA (+), desmin (+), GFAP (−), EMA (−), Ki-67 (−)

NA

Present case

Endothelial cells: CD34 (+), spindle cell: αSMA (+), h-Caldesmon (+), calponin (+), EMA (−), S100 (−), CD34 (−)

Cavernous

Abbreviations: AE1/AE3, antikeratin; EMA, epithelial membrane antigen; GFAP, glial fibrillary acidic protein; MSA, muscle-specific actin; NA, not available; SMA, smooth muscle actin.


According to our review, typically ALMs were mostly of a solid tumor type and were isointense on a T1-weighted MRI, hyperintense on a T2-weighted MRI, and homogeneously enhanced after intravenous administrations of gadolinium. Radiologic findings in our case were similar to that of most previous reports (Table 2). Bone erosion is considered a rare radiologic finding in ALM. There is only one report of bone erosion in the literature.[2] We focus here on two radiologic findings that include blush enhancement on enhanced MR, and small nodular enhancement on angiography, and enhanced CT. In our case, the tumor heterogeneously enhanced on an MRI. This blush enhancement seemed to extend from the center of the tumor like a hemangioma ([Fig. 4A–C]). Colnat-Coulbois et al previously recognized these characteristic findings. They also stated that the tumor heterogeneously enhanced in the early phase after intravenous administrations of gadolinium; however, it homogeneously enhanced in the late phase.[1] Second, there were small nodular enhancement in angiography and enhanced CT images ([Fig. 4D, E]). These findings are new radiologic findings of intracranial angioleiomyoma, similar to that of hemangioma. This similarity to hemangioma is understandable because ALMs are considered on a spectrum between hemangioma and leiomyoma. Presently, it is considered difficult to distinguish intracranial ALMs from meningioma, schwannoma, cavernous hemangioma, and hemangioblastoma. We conclude that cavernous hemangioma and hemangioblastoma can be distinguished easily from intracranial ALMs. This is because typically cavernous hemangiomas are often hyperintense on a T1-weighted MRI, hyperintense on a T2-weighted MRI, and have a hemosiderin rim.[3] In contrast, hemangioblastomas often have cysts, flow void on a T1- and T2-weighted MRI, and angiography shows the feeding artery. Otherwise, it is difficult to distinguish intracranial ALMs from meningiomas or schwannomas. The dural relationship of ALMs tends to confuse the diagnosis compared with that of meningioma. However, blush enhancement and the small nodular enhancement such as hemangioma may differ from meningioma or schwannoma ([Fig. 4]).

Zoom Image
Fig. 4 Preoperative neuroradiologic findings. (A–C) Contrast-enhanced T1-weighted magnetic resonance images. (D) Enhanced computed tomography scans. (E) Preoperative cerebral angiography (right internal carotid angiography). Note the tumor (circle) with small labeled nodules within (arrow).

Histopathologically, ALMs have been subdivided into three types: solid, venous, and cavernous ([Table 3]). The solid type is composed of small vessels and compacted smooth muscle. The venous type has numerous thick-walled vessels and smooth muscle bundles that are not as compact. The cavernous type is composed of dilated vessels and few intervening smooth muscle cells. According to Hachisuga et al, a total of 562 cases of ALMs were separated into 374 cases (66%) of the solid type, 127 (23%) of the venous type, and 61 (11%) of the cavernous type.[4] Otherwise, in the intracranial ALMs, the cavernous type was more frequently found than other types in previous reports (seven cases: cavernous type; two cases: venous type; two cases: solid type; one case: mixed type; two cases: unknown) (p = 0.04). Ramesh et al and Tracy et al observed that the solid type and the venous type were found mostly in females, and the cavernous type was found mainly in males.[11] [14] Therefore, because since intracranial ALMs are mainly found in males, they are often classified into the cavernous type, unlike common ALMs.

Currently, there is no stated appropriate surgical approach for intracranial ALMs. According to previous reports, the surgical approach for intracranial ALMs varies by location. The surgical approach also differs in cavernous sinus ALMs. In a previous case, Figueiredo et al selected an epidural approach, but Colnat-Coulbois et al performed a transsylvian subdural approach.[1] [2] Zhou et al did not detail their surgical approach.[3] Because ALMs are considered on a spectrum of conditions between hemangioma and leiomyoma histopathologically, ALMs are expected to be differentiated from the mesoderm. Dura mater is derived from the ectomeninx, which is of mixed paraxial mesodermal and neural crest origin.[15] Furthermore, in the previous 14 cases, 11 cases were found in the extradural lesion or in the peridural lesion (Table 1). From the above, ALMs are often expected to be an epidural tumor. Therefore, we should select the epidural approach and need to consider the radiologic findings of the tumor carefully.

In our review of the previous reports, intracranial ALMs differ from ALMs that occur in the extremities. Intracranial ALMs appear more frequent in men than women. The cavernous type is the most common type pathologically, and they occur often in the epiperidural lesion. Because cavernous sinus ALM occurs in the interdural space, an epidural approach should be selected. In addition, it is necessary to include cavernous sinus ALM into the differential diagnosis of the cavernous sinus tumor. The blush enhancement and the small nodular enhancement in enhanced CT and angiography, such as hemangioma, are helpful radiologic findings to distinguish cavernous sinus ALM from other differential diagnoses.


#
#

Disclosure

The authors report no conflict of interest concerning the materials or methods used in this or the findings specified in this paper.

  • References

  • 1 Colnat-Coulbois S, Schmitt E, Klein O, Weinbreck N, Auque J, Civit T. Angioleiomyoma of the cavernous sinus: case report. Neurosurgery 2008; 62 (1) E257 –E258; discussion E258
  • 2 Figueiredo EG, Gomes M, Vellutini E, Rosemberg S, Marino Jr R. Angioleiomyoma of the cavernous sinus: case report. Neurosurgery 2005; 56 (2) E411 ; discussion E411
  • 3 Zhou Z, Yu M, Yang S, Zhou J, Sun R, Yang G. Dural angioleiomyoma of the middle cranial fossa: a case report and review of the literature. Brain Tumor Pathol 2013; 30 (2) 117-121
  • 4 Hachisuga T, Hashimoto H, Enjoji M. Angioleiomyoma. A clinicopathologic reappraisal of 562 cases. Cancer 1984; 54 (1) 126-130
  • 5 Gasco J, Franklin B, Rangel-Castilla L, Campbell GA, Eltorky M, Salinas P. Infratentorial angioleiomyoma: a new location for a rare neoplastic entity. J Neurosurg 2009; 110 (4) 670-674
  • 6 Karagama YG, Bridges LR, van Hille PT. Angioleiomyoma of the internal auditory meatus: a rare occurrence in the internal auditory canal. Ear Nose Throat J 2005; 84 (4) 216-218
  • 7 Kohan D, Downey LL, Lim J, Cohen NL, Elowitz E. Uncommon lesions presenting as tumors of the internal auditory canal and cerebellopontine angle. Am J Otol 1997; 18 (3) 386-392
  • 8 Lach B, Duncan E, Rippstein P, Benoit BG. Primary intracranial pleomorphic angioleiomyoma—a new morphologic variant. An immunohistochemical and electron microscopic study. Cancer 1994; 74 (7) 1915-1920
  • 9 Ravikumar C, Veerendrakumar M, Hegde T, Nagaraja D, Jayakumar PN, Shankar SK. Basal ganglionic angioleiomyoma. Clin Neurol Neurosurg 1996; 98 (3) 253-257
  • 10 Shinde SV, Shah AB, Baviskar RB, Deshpande JR. Primary intracranial multicentric angioleiomyomas. Neurol India 2012; 60 (1) 115-117
  • 11 Conner TM, Waziri A, Kleinschmidt-Demasters BK. Angioleiomyomas of the dura: rare entities that lack KRIT1 mutations. Am J Surg Pathol 2012; 36 (4) 526-533
  • 12 Vijayasaradhi M, Uppin SG, Sreedhar V, Sundaram C, Panigrahi MK. Frontal intradiploic angioleiomyoma. J Neurosurg Pediatr 2008; 2 (4) 266-268
  • 13 Xu Y, Jing Y, Ma S , et al. Primary angioleiomyoma in the sellar region: a case report and literature review. Clin Neuropathol 2010; 29 (1) 21-25
  • 14 Ramesh P, Annapureddy SR, Khan F, Sutaria PD. Angioleiomyoma: a clinical, pathological and radiological review. Int J Clin Pract 2004; 58 (6) 587-591
  • 15 Huang MC, van Loveren H . Anatomy and biology of the leptomeninges. In: Al-Mefty O, ed. Meningiomas. New York, NY: Raven Press; 1991. :Chapter 3

Address for correspondence

Yu Teranishi, MD
Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital
4-22-1, Nakano, Nakano-ku, Tokyo
Japan   

  • References

  • 1 Colnat-Coulbois S, Schmitt E, Klein O, Weinbreck N, Auque J, Civit T. Angioleiomyoma of the cavernous sinus: case report. Neurosurgery 2008; 62 (1) E257 –E258; discussion E258
  • 2 Figueiredo EG, Gomes M, Vellutini E, Rosemberg S, Marino Jr R. Angioleiomyoma of the cavernous sinus: case report. Neurosurgery 2005; 56 (2) E411 ; discussion E411
  • 3 Zhou Z, Yu M, Yang S, Zhou J, Sun R, Yang G. Dural angioleiomyoma of the middle cranial fossa: a case report and review of the literature. Brain Tumor Pathol 2013; 30 (2) 117-121
  • 4 Hachisuga T, Hashimoto H, Enjoji M. Angioleiomyoma. A clinicopathologic reappraisal of 562 cases. Cancer 1984; 54 (1) 126-130
  • 5 Gasco J, Franklin B, Rangel-Castilla L, Campbell GA, Eltorky M, Salinas P. Infratentorial angioleiomyoma: a new location for a rare neoplastic entity. J Neurosurg 2009; 110 (4) 670-674
  • 6 Karagama YG, Bridges LR, van Hille PT. Angioleiomyoma of the internal auditory meatus: a rare occurrence in the internal auditory canal. Ear Nose Throat J 2005; 84 (4) 216-218
  • 7 Kohan D, Downey LL, Lim J, Cohen NL, Elowitz E. Uncommon lesions presenting as tumors of the internal auditory canal and cerebellopontine angle. Am J Otol 1997; 18 (3) 386-392
  • 8 Lach B, Duncan E, Rippstein P, Benoit BG. Primary intracranial pleomorphic angioleiomyoma—a new morphologic variant. An immunohistochemical and electron microscopic study. Cancer 1994; 74 (7) 1915-1920
  • 9 Ravikumar C, Veerendrakumar M, Hegde T, Nagaraja D, Jayakumar PN, Shankar SK. Basal ganglionic angioleiomyoma. Clin Neurol Neurosurg 1996; 98 (3) 253-257
  • 10 Shinde SV, Shah AB, Baviskar RB, Deshpande JR. Primary intracranial multicentric angioleiomyomas. Neurol India 2012; 60 (1) 115-117
  • 11 Conner TM, Waziri A, Kleinschmidt-Demasters BK. Angioleiomyomas of the dura: rare entities that lack KRIT1 mutations. Am J Surg Pathol 2012; 36 (4) 526-533
  • 12 Vijayasaradhi M, Uppin SG, Sreedhar V, Sundaram C, Panigrahi MK. Frontal intradiploic angioleiomyoma. J Neurosurg Pediatr 2008; 2 (4) 266-268
  • 13 Xu Y, Jing Y, Ma S , et al. Primary angioleiomyoma in the sellar region: a case report and literature review. Clin Neuropathol 2010; 29 (1) 21-25
  • 14 Ramesh P, Annapureddy SR, Khan F, Sutaria PD. Angioleiomyoma: a clinical, pathological and radiological review. Int J Clin Pract 2004; 58 (6) 587-591
  • 15 Huang MC, van Loveren H . Anatomy and biology of the leptomeninges. In: Al-Mefty O, ed. Meningiomas. New York, NY: Raven Press; 1991. :Chapter 3

Zoom Image
Fig. 1 Preoperative magnetic resonance imaging findings. (A) Axial T1: The lesion showed isointensity. (B) Contrast-enhanced axial T1: The lesion showed heterogenous enhancement. (C) Axial T2: The lesion showed hyperintensity. (D) Axial diffusion-weighted image: The lesion showed hypointensity. (E) Coronal constructive interference in a steady state: The lesion revealed that the tumor was located between the layers of the lateral wall of the cavernous sinus. Note the tumor (circle).
Zoom Image
Fig. 2 Pathologic findings. (A–C) Dilated vascular channels intermingled with smooth muscle bundles (hematoxylin and eosin, ×100, ×400). (D) Endothelial cells showing strong positivity for CD34 (immunohistochemistry, ×400). (E–G) Smooth muscle bundles showing strong positivity for Calponin, h-Caldesmon, and αSMA (immunohistochemistry, ×400). (H) Ki-67 index was 2.1%.
Zoom Image
Fig. 3 Postoperative neuroradiologic findings. (A) T1-weighted magnetic resonance (MR) images. (B) Contrast-enhanced T1-weighted MR images. (C) Computed tomography scans.
Zoom Image
Fig. 4 Preoperative neuroradiologic findings. (A–C) Contrast-enhanced T1-weighted magnetic resonance images. (D) Enhanced computed tomography scans. (E) Preoperative cerebral angiography (right internal carotid angiography). Note the tumor (circle) with small labeled nodules within (arrow).